Selective expression of stromal-derived factor-1 in the capillary vascular endothelium plays a role in Kaposi sarcoma pathogenesis

被引:49
作者
Yao, L
Salvucci, C
Cardones, AR
Hwang, ST
Aoki, Y
De La Luz Sierra, M
Sajewicz, A
Pittaluga, S
Yarchoan, R
Tosato, G
机构
[1] NCI, Expt Transplantat & Immunol Branch, CCR, NIH, Bethesda, MD 20892 USA
[2] NCI, Dermatol Branch, CCR, NIH, Bethesda, MD 20892 USA
[3] NCI, Pathol Lab, CCR, NIH, Bethesda, MD 20892 USA
[4] NCI, HIV & AIDS Malignancy Branch, CCR, NIH, Bethesda, MD 20892 USA
关键词
D O I
10.1182/blood-2003-02-0641
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Kaposi sarcoma (KS), the most common neoplasm in patients with AIDS, typically presents with multiple skin lesions characterized by "spindle cells," the vast majority of which are infected with KSHV (Kaposi sarcoma herpes' virus, also named HHV-8). In patients with AIDS, the presence of cell-associated KSHV DNA in blood is predictive of subsequent KS development, but the mechanisms by which circulating KSHV-infected cells contribute to AIDS-KS pathogenesis are unclear. Here, we show that the chemokine stromal-derived factor-1 (SDF-1), which is constitutively expressed by skin capillary endothelium and displayed on the endothelial cell surface in association with heparan sulfate, can trigger specific arrest of KSHV-infected cat Is under physiologic, shear flow conditions. Moreover, in the presence of soluble SDF-1 gradients, SDF-1 expressed on the endothelial barrier can promote transendothelial migration of KSHV-infected, cells. By triggering specific adhesion of circulating KSHV-infected cells and favoring their entry into the extravascular cutaneous space, endothelial cell-associated SDF-1 in cutaneous capillaries may dictate the preferential occurrence of KS in the skin. (C) 2003 by The American Society of Hematology.
引用
收藏
页码:3900 / 3905
页数:6
相关论文
共 49 条
[1]   The chemokine SDF-1 is a chemoattractant for human CD34(+) hematopoietic progenitor cells and provides a new mechanism to explain the mobilization of CD34(+) progenitors to peripheral blood [J].
Aiuti, A ;
Webb, IJ ;
Bleul, C ;
Springer, T ;
GutierrezRamos, JC .
JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 185 (01) :111-120
[2]   Integrin α3β1 (CD 49c/29) is a cellular receptor for Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) entry into the target cells [J].
Akula, SM ;
Pramod, NP ;
Wang, FZ ;
Chandran, B .
CELL, 2002, 108 (03) :407-419
[3]   The angiogenesis induced by HIV-1 Tat protein is mediated by the Flk-1/KDR receptor on vascular endothelial cells [J].
Albini, A ;
Soldi, R ;
Giunciuglio, D ;
Giraudo, E ;
Benelli, R ;
Primo, L ;
Noonan, D ;
Salio, M ;
Camussi, G ;
Rockl, W ;
Bussolino, F .
NATURE MEDICINE, 1996, 2 (12) :1371-1375
[4]   Stromal cell-derived factor-1α associates with heparan sulfates through the first β-strand of the chemokine [J].
Amara, A ;
Lorthioir, O ;
Valenzuela, A ;
Magerus, A ;
Thelen, M ;
Montes, M ;
Virelizier, JL ;
Delepierre, M ;
Baleux, F ;
Lortat-Jacob, H ;
Arenzana-Seisdedos, F .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (34) :23916-23925
[5]   HERPES-LIKE SEQUENCES IN HIV-INFECTED AND UNINFECTED KAPOSIS-SARCOMA PATIENTS [J].
AMBROZIAK, JA ;
BLACKBOURN, DJ ;
HERNDIER, BG ;
GLOGAU, RG ;
GULLETT, JH ;
MCDONALD, AR ;
LENNETTE, ET ;
LEVY, JA .
SCIENCE, 1995, 268 (5210) :582-583
[6]   Kaposi's sarcoma-associated herpesvirus-encoded interleukin-6 [J].
Aoki, Y ;
Jones, KD ;
Tosato, G .
JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH, 2000, 9 (02) :137-145
[7]   Aids-related malignancies [J].
Boshoff, C ;
Weiss, R .
NATURE REVIEWS CANCER, 2002, 2 (05) :373-382
[8]   Chemokines in tissue-specific and microenvironment-specific lymphocyte homing [J].
Campbell, JJ ;
Butcher, EC .
CURRENT OPINION IN IMMUNOLOGY, 2000, 12 (03) :336-341
[9]   Chemokines and the arrest of lymphocytes rolling under flow conditions [J].
Campbell, JJ ;
Hedrick, J ;
Zlotnik, A ;
Siani, MA ;
Thompson, DA ;
Butcher, EC .
SCIENCE, 1998, 279 (5349) :381-384
[10]   Relationship of human herpesvirus 8 peripheral blood virus load and Kaposi's sarcoma clinical stage [J].
Campbell, TB ;
Borok, M ;
Gwanzura, L ;
MaWhinney, S ;
White, IE ;
Ndemera, B ;
Gudza, I ;
Fitzpatrick, L ;
Schooley, RT .
AIDS, 2000, 14 (14) :2109-2116